Regeneron Pharmaceuticals To Buy 23andMe and Its Data For $256 Million
Regeneron Pharmaceuticals To Buy 23andMe and Its Data For $256 Million Regeneron Pharmaceuticals is set to acquire a majority of 23andMe’s assets for a whopping $256 million. This deal includes…
